BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 8812)

  • 1. Generalization of morphine and lysergic acid diethylamide (LSD) stimulus properties to narcotic analgesics.
    Hirschhorn ID; Rosecrans JA
    Psychopharmacology (Berl); 1976 May; 47(1):65-9. PubMed ID: 8812
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pentazocine, cyclazocine, and nalorphine as discriminative stimuli.
    Hirschhorn ID
    Psychopharmacology (Berl); 1977 Nov; 54(3):289-94. PubMed ID: 413147
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The discriminative stimulus properties of cyclazocine: generalization studies involving nalorphine, morphine and LSD.
    Rosecrans JA; Chance WT; Spencer RM
    Res Commun Chem Pathol Pharmacol; 1978 May; 20(2):221-37. PubMed ID: 674812
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differentiation between the stimulus effects of (+)-lysergic acid diethylamide and lisuride using a three-choice, drug discrimination procedure.
    Callahan PM; Appel JB
    Psychopharmacology (Berl); 1990; 100(1):13-8. PubMed ID: 2296621
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Non-opioid psychotomimetic-like discriminative stimulus properties of N-allylnormetazocine (SKF 10,047) in the rat.
    Shearman GT; Herz A
    Eur J Pharmacol; 1982 Aug; 82(3-4):167-72. PubMed ID: 6290235
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nitrous oxide generalizes to a discriminative stimulus produced by ethylketocyclazocine but not morphine.
    Hynes MD; Hymson DL
    Eur J Pharmacol; 1984 Oct; 105(1-2):155-9. PubMed ID: 6149142
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of the discriminative effects of morphine in the rat.
    Shannon HE; Holtzman SG
    J Pharmacol Exp Ther; 1976 Jul; 198(1):54-65. PubMed ID: 6794
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Further evaluation of the discriminative effects of morphine in the rat.
    Shannon HE; Holtzman SG
    J Pharmacol Exp Ther; 1977 Apr; 201(1):55-66. PubMed ID: 15104
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differences in the stimulus properties of barbital and hallucinogens.
    Hirschhorn ID; Winter JC
    Pharmacol Biochem Behav; 1975; 3(3):343-7. PubMed ID: 1153438
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antagonism of the discriminative effects of ethylketazocine, cyclazocine, and nalorphine in macaques.
    Young AM; Stephens KR
    Psychopharmacology (Berl); 1984; 84(3):356-61. PubMed ID: 6151208
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Complex discriminative stimulus properties of (+)lysergic acid diethylamide (LSD) in C57Bl/6J mice.
    Benneyworth MA; Smith RL; Barrett RJ; Sanders-Bush E
    Psychopharmacology (Berl); 2005 Jun; 179(4):854-62. PubMed ID: 15645221
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discriminative stimulus properties of fentanyl and morphine: tolerance and dependence.
    Colpaert FC; Kuyps JJ; Niemegeers CJ; Janssen PA
    Pharmacol Biochem Behav; 1976 Oct; 5(4):401-8. PubMed ID: 12518
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discriminative effects of cyclazocine in the squirrel monkey.
    Schaefer GJ; Holtzman SG
    J Pharmacol Exp Ther; 1978 May; 205(2):291-301. PubMed ID: 417173
    [TBL] [Abstract][Full Text] [Related]  

  • 14. THE CLINICAL EVALUATION OF MORPHINE AND ITS SUBSTITUTES AS ANALGESICS.
    LASAGNA L
    Pharmacol Rev; 1964 Mar; 16():47-83. PubMed ID: 14165239
    [No Abstract]   [Full Text] [Related]  

  • 15. Stimulus properties of the narcotic antagonist pentazocine: similarity to morphine and antagonism by naloxone.
    Kuhn DM; Greenberg I; Appel JB
    J Pharmacol Exp Ther; 1976 Jan; 196(1):121-7. PubMed ID: 1246006
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interactions of clozapine with the stimulus effects of DOM and LSD.
    Palumbo PA; Winter JC
    Pharmacol Biochem Behav; 1994 Sep; 49(1):115-20. PubMed ID: 7816860
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Further characterization of the three-choice morphine, cyclazocine and saline discrimination paradigm: opioids with agonist and antagonist properties.
    White JM; Holtzman SG
    J Pharmacol Exp Ther; 1983 Jan; 224(1):95-9. PubMed ID: 6336785
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discriminative stimulus properties of nalorphine in the rhesus monkeys.
    Tang AH; Code RA
    J Pharmacol Exp Ther; 1983 Dec; 227(3):563-9. PubMed ID: 6317838
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sensitization and tolerance to the discriminative stimulus effects of mu-opioid agonists.
    Paronis CA; Holtzman SG
    Psychopharmacology (Berl); 1994 May; 114(4):601-10. PubMed ID: 7855222
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug discrimination studies.
    Holtzman SG
    Drug Alcohol Depend; 1985 Feb; 14(3-4):263-82. PubMed ID: 2859972
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.